Novo Nordisk is expected to lose patent protection in countries home to 40 percent of the world's population, with generics anticipated in the coming months in China, Canada, Brazil, Turkey and South Africa
Here's what we run and why: Comprehensive Metabolic Panel (CMP) Your kidneys and liver are processing everything
We stock them at the clinic if you cant find one locally
No, routine vaccinations including annual influenza and COVID-19 vaccines remain appropriate and important for patients taking semaglutide
Individual responses vary depending on the condition being addressed and baseline nutritional status
Research on Gila monster venom identified a peptide called exendin-4, which mimics GLP-1 but has a longer half-life, making it suitable for drug development